Keywords: Traumatic Brain Injury, Inflammation
Motivation: Transcranial low-level near-infrared (NIR) light therapy (LLLT) has been emerging as a therapeutic intervention for traumatic brain injury (TBI).
Goal(s): The goal of this study was to assess the metabolic responses to the administration of LLLT in patients with moderate TBI.
Approach: We used serial 2D MR spectroscopic imaging to measure metabolite concentrations in TBI participants who were either treated with LLLT or with sham.
Results: Sham-treated participants showed a significant increase in myo-inositol/N-acetyl aspartate (mI/NAA) in the corpus callosum 3 months post injury indicating lasting inflammation and neuronal injury, while LLLT treated participants’ mI/NAA ratios remained unchanged.
Impact: This longitudinal study suggests a neuroprotective effect of acute administration of LLLT using MRS on individuals with moderate TBI.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords